Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339,200,672
-
Total 13F shares
-
122,352,875
-
Share change
-
+2,391,703
-
Total reported value
-
$1,039,654,594
-
Price per share
-
$8.50
-
Number of holders
-
99
-
Value change
-
+$18,872,709
-
Number of buys
-
58
-
Number of sells
-
34
Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q4 2021
As of 31 Dec 2021,
Nuvation Bio Inc. - Common Stock (NUVB) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,352,875 shares.
The largest 10 holders included
Omega Fund Management, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., BAUPOST GROUP LLC/MA, Avidity Partners Management LP, CITADEL ADVISORS LLC, BOXER CAPITAL, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., and Redmile Group, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.